Search Results - "Yu, Yuanhuan"

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    A non-invasive far-red light-induced split-Cre recombinase system for controllable genome engineering in mice by Wu, Jiali, Wang, Meiyan, Yang, Xueping, Yi, Chengwei, Jiang, Jian, Yu, Yuanhuan, Ye, Haifeng

    Published in Nature communications (24-07-2020)
    “…The Cre- loxP recombination system is a powerful tool for genetic manipulation. However, there are widely recognized limitations with chemically inducible Cre-…”
    Get full text
    Journal Article
  2. 2

    Synthetic far-red light-mediated CRISPR-dCas9 device for inducing functional neuronal differentiation by Shao, Jiawei, Wang, Meiyan, Yu, Guiling, Zhu, Sucheng, Yu, Yuanhuan, Heng, Boon Chin, Wu, Jiali, Ye, Haifeng

    “…The ability to control the activity of CRISPR-dCas9 with precise spatiotemporal resolution will enable tight genome regulation of user-defined endogenous genes…”
    Get full text
    Journal Article
  3. 3

    Optogenetic-controlled immunotherapeutic designer cells for post-surgical cancer immunotherapy by Yu, Yuanhuan, Wu, Xin, Wang, Meiyan, Liu, Wenjing, Zhang, Li, Zhang, Ying, Hu, Zhilin, Zhou, Xuantong, Jiang, Wenzheng, Zou, Qiang, Cai, Fengfeng, Ye, Haifeng

    Published in Nature communications (26-10-2022)
    “…Surgical resection is the main treatment option for most solid tumors, yet cancer recurrence after surgical resection remains a significant challenge in cancer…”
    Get full text
    Journal Article
  4. 4

    AAV-delivered muscone-induced transgene system for treating chronic diseases in mice via inhalation by Wu, Xin, Yu, Yuanhuan, Wang, Meiyan, Dai, Di, Yin, Jianli, Liu, Wenjing, Kong, Deqiang, Tang, Shasha, Meng, Meiyao, Gao, Tian, Zhang, Yuanjin, Zhou, Yang, Guan, Ningzi, Zhao, Shangang, Ye, Haifeng

    Published in Nature communications (06-02-2024)
    “…Gene therapies provide treatment options for many diseases, but the safe and long-term control of therapeutic transgene expression remains a primary issue for…”
    Get full text
    Journal Article
  5. 5

    Engineering a far-red light-activated split-Cas9 system for remote-controlled genome editing of internal organs and tumors by Yu, Yuanhuan, Wu, Xin, Guan, Ningzi, Shao, Jiawei, Li, Huiying, Chen, Yuxuan, Ping, Yuan, Li, Dali, Ye, Haifeng

    Published in Science advances (01-07-2020)
    “…It is widely understood that CRISPR-Cas9 technology is revolutionary, with well-recognized issues including the potential for off-target edits and the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Constructing a Smartphone-Controlled Semiautomatic Theranostic System for Glucose Homeostasis in Diabetic Mice by Yu, Guiling, Yu, Yuanhuan, Ye, Haifeng

    “…With the development of mobile communication technology, smartphones have been used in point-of-care technologies (POCTs) as an important part of telemedicine…”
    Get more information
    Journal Article
  8. 8

    Smartphone-controlled optogenetically engineered cells enable semiautomatic glucose homeostasis in diabetic mice by Shao, Jiawei, Xue, Shuai, Yu, Guiling, Yu, Yuanhuan, Yang, Xueping, Bai, Yu, Zhu, Sucheng, Yang, Linfeng, Yin, Jianli, Wang, Yidan, Liao, Shuyong, Guo, Sanwei, Xie, Mingqi, Fussenegger, Martin, Ye, Haifeng

    Published in Science translational medicine (26-04-2017)
    “…With the increasingly dominant role of smartphones in our lives, mobile health care systems integrating advanced point-of-care technologies to manage chronic…”
    Get more information
    Journal Article
  9. 9

    A Synthetic-Biology-Inspired Therapeutic Strategy for Targeting and Treating Hepatogenous Diabetes by Xue, Shuai, Yin, Jianli, Shao, Jiawei, Yu, Yuanhuan, Yang, Linfeng, Wang, Yidan, Xie, Mingqi, Fussenegger, Martin, Ye, Haifeng

    Published in Molecular therapy (01-02-2017)
    “…Hepatogenous diabetes is a complex disease that is typified by the simultaneous presence of type 2 diabetes and many forms of liver disease. The chief…”
    Get full text
    Journal Article
  10. 10
  11. 11

    Sonogenetics-controlled synthetic designer cells for cancer therapy in tumor mouse models by Gao, Tian, Niu, Lingxue, Wu, Xin, Dai, Di, Zhou, Yang, Liu, Mengyao, Wu, Ke, Yu, Yuanhuan, Guan, Ningzi, Ye, Haifeng

    Published in Cell reports. Medicine (21-05-2024)
    “…Bacteria-based therapies are powerful strategies for cancer therapy, yet their clinical application is limited by a lack of tunable genetic switches to safely…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Comparison of properties of solid phase epitaxial silicon on sapphire films recrystallized by rapid thermal annealing and furnace annealing by Wang, Qiyuan, Zan, Yude, Wang, Jianhua, Yu, Yuanhuan

    “…Chemically vapour deposited silicon on sapphire (SOS) films 0.25 μm thick were implanted with 28Si + and recrystallized in solid phase by furnace annealing…”
    Get full text
    Journal Article Conference Proceeding
  14. 14

    Fabrication of novel double-hetero-epitaxial SOI structure Si/γ-Al 2O 3/Si by Tan, Liwen, Wang, Qiyuan, Wang, Jun, Yu, Yuanhuan, Liu, Zhongli, Lin, Lanying

    Published in Journal of crystal growth (2003)
    “…In this paper, we report the fabrication of Si-based double-hetero-epitaxial silicon on insulator (SOI) structure Si/γ-Al 2O 3/Si. Firstly, single crystalline…”
    Get full text
    Journal Article
  15. 15

    Very low-pressure VLP-CVD growth of high quality γ-Al 2O 3 films on silicon by multi-step process by Tan, Liwen, Zan, Yude, Wang, Jun, Wang, Qiyuan, Yu, Yuanhuan, Wang, Shurui, Liu, Zhongli, Lin, Lanying

    Published in Journal of crystal growth (2002)
    “…γ-Al 2O 3 films were grown on Si (1 0 0) substrates using the sources of TMA (Al(CH 3) 3) and O 2 by very low-pressure chemical vapor deposition. The effects…”
    Get full text
    Journal Article
  16. 16

    Improvement of CMOS/SOS devices characteristics by a modified solid phase epitaxy by Liu Zhongli, He Zhijing, Yu Fang, Nie Jiping, Yu Yuanhuan

    “…CMOS/SOS devices have lower carrier mobility and higher channel leakage current than bulk silicon CMOS devices. These mainly result from the defects in the…”
    Get full text
    Conference Proceeding